Cargando…

Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system

Pro-inflammation, which is developed due to the increased production of cytokines, mainly interleukin-6 (IL-6), during the working of immune system pathways, becomes a major concern these days for many researchers. So, it is desired to design, screen, and synthesize new molecules with multi-parametr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Gurmeet, Bansal, Manisha, Rehman, Hafiz Muzzammel, Kaur, Mandeep, Kaur, Amandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972316/
https://www.ncbi.nlm.nih.gov/pubmed/36853528
http://dx.doi.org/10.1007/s11030-023-10616-8
_version_ 1784898296480792576
author Kaur, Gurmeet
Bansal, Manisha
Rehman, Hafiz Muzzammel
Kaur, Mandeep
Kaur, Amandeep
author_facet Kaur, Gurmeet
Bansal, Manisha
Rehman, Hafiz Muzzammel
Kaur, Mandeep
Kaur, Amandeep
author_sort Kaur, Gurmeet
collection PubMed
description Pro-inflammation, which is developed due to the increased production of cytokines, mainly interleukin-6 (IL-6), during the working of immune system pathways, becomes a major concern these days for many researchers. So, it is desired to design, screen, and synthesize new molecules with multi-parametric features showing their efficacy for Toll-like receptors (TLRs) and inhibiting the disease-causing receptor sites like viral infections, cancers, etc. along with controlling inflammation, fever, and other side effects during such pathways. Further, looking at the literature, curcumin a multi-targeted agent is showing its efficiency toward various receptor sites involved in many diseases as mentioned above. This fascinated us to build up new molecules which behave like curcumin with minimum side effects. In silico studies, involving ADMET studies, toxicological data, and docking analyses, of newly synthesized compounds (3–5) along with tautomers of curcumin i.e., (1–2), and some reported compounds like 9 and 10 have been studied in detail. Great emphasis has been made on analyzing binding energies, protein–ligand structural interactions, stabilization of newly synthesized molecules against various selected receptor sites using such computational tools. Compound 3 is the most efficient multifunctional agent, which has shown its potential toward most of the receptor sites in docking analysis. It has also responded well in Molecular dynamics (MD) simulation toward 5ZLN, 4RJ3, 4YO9, 4YOJ, and 1I1R sites. Finally, studies were extended to understand in vitro anti-inflammatory activity for particularly compound 3 in comparison to diclofenac and curcumin, which signifies the efficiency of compound 3. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11030-023-10616-8.
format Online
Article
Text
id pubmed-9972316
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99723162023-02-28 Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system Kaur, Gurmeet Bansal, Manisha Rehman, Hafiz Muzzammel Kaur, Mandeep Kaur, Amandeep Mol Divers Original Article Pro-inflammation, which is developed due to the increased production of cytokines, mainly interleukin-6 (IL-6), during the working of immune system pathways, becomes a major concern these days for many researchers. So, it is desired to design, screen, and synthesize new molecules with multi-parametric features showing their efficacy for Toll-like receptors (TLRs) and inhibiting the disease-causing receptor sites like viral infections, cancers, etc. along with controlling inflammation, fever, and other side effects during such pathways. Further, looking at the literature, curcumin a multi-targeted agent is showing its efficiency toward various receptor sites involved in many diseases as mentioned above. This fascinated us to build up new molecules which behave like curcumin with minimum side effects. In silico studies, involving ADMET studies, toxicological data, and docking analyses, of newly synthesized compounds (3–5) along with tautomers of curcumin i.e., (1–2), and some reported compounds like 9 and 10 have been studied in detail. Great emphasis has been made on analyzing binding energies, protein–ligand structural interactions, stabilization of newly synthesized molecules against various selected receptor sites using such computational tools. Compound 3 is the most efficient multifunctional agent, which has shown its potential toward most of the receptor sites in docking analysis. It has also responded well in Molecular dynamics (MD) simulation toward 5ZLN, 4RJ3, 4YO9, 4YOJ, and 1I1R sites. Finally, studies were extended to understand in vitro anti-inflammatory activity for particularly compound 3 in comparison to diclofenac and curcumin, which signifies the efficiency of compound 3. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11030-023-10616-8. Springer International Publishing 2023-02-28 /pmc/articles/PMC9972316/ /pubmed/36853528 http://dx.doi.org/10.1007/s11030-023-10616-8 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Kaur, Gurmeet
Bansal, Manisha
Rehman, Hafiz Muzzammel
Kaur, Mandeep
Kaur, Amandeep
Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system
title Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system
title_full Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system
title_fullStr Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system
title_full_unstemmed Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system
title_short Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system
title_sort synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972316/
https://www.ncbi.nlm.nih.gov/pubmed/36853528
http://dx.doi.org/10.1007/s11030-023-10616-8
work_keys_str_mv AT kaurgurmeet synthesisandstudiesofnewpurinespyrimidinederivativesasmultitargetedagentsinvolvingvariousreceptorsitesintheimmunesystem
AT bansalmanisha synthesisandstudiesofnewpurinespyrimidinederivativesasmultitargetedagentsinvolvingvariousreceptorsitesintheimmunesystem
AT rehmanhafizmuzzammel synthesisandstudiesofnewpurinespyrimidinederivativesasmultitargetedagentsinvolvingvariousreceptorsitesintheimmunesystem
AT kaurmandeep synthesisandstudiesofnewpurinespyrimidinederivativesasmultitargetedagentsinvolvingvariousreceptorsitesintheimmunesystem
AT kauramandeep synthesisandstudiesofnewpurinespyrimidinederivativesasmultitargetedagentsinvolvingvariousreceptorsitesintheimmunesystem